[Electrophoretic serous patterns (proteins, lipoproteins and glycoproteins) of diabetics during treatment with N-sulfanilyl-N'-butyl urea and N-tolyl-sulfonyl-N'-butyl urea].
D003920:Diabetes Mellitus / Q000097:blood*; D008074:Lipoproteins; D000077145:Sulfanilamide; D013424:Sulfanilamides / Q000031:analogs & derivatives; D013449:Sulfonamides / Q000494:pharmacology*; D014508:Urea / Q000031:analogs & derivatives
D008074:Lipoproteins; D013424:Sulfanilamides; D013449:Sulfonamides; D000077145:Sulfanilamide; D014508:Urea
DIABETES MELLITUS/blood in; SULFANILAMIDE/related compounds; SULFONAMIDES/effects; UREA/related compounds
Quadri sierici elettroforetici (proteici, lipo-proteici e glico-proteici) di diabetici in corso di trattamento con N1-sulfanil-N2-butilurea e N1-(4-metil-benzosulfanil)-N2-butilurea.